Form 4: Teladoc Health Executive Andrew Turitz Reports Stock Transactions
SEC Form 4 Filing
EVP Andrew Turitz of Teladoc Health reports the acquisition and disposal of common stock and derivative securities, including performance stock units and restricted stock units.
Summary
- Andrew Turitz, EVP of Corporate Development at Teladoc Health, filed a Form 4 detailing changes in beneficial ownership.
- On May 31, 2024, Turitz acquired shares through the conversion of performance stock units and restricted stock units.
- Specifically, 1,056 shares were acquired from performance stock units, 1,348 shares from restricted stock units, and 3,100 shares from additional restricted stock units.
- On June 3, 2024, Turitz sold 1,627 shares at a price of $11.157 per share to cover tax withholding obligations related to the vesting of stock units.
- Following these transactions, Turitz beneficially owns 37,659 shares of common stock.
- Turitz also holds derivative securities, including 7,397 performance stock units, 4,044 restricted stock units from a 2022 grant, and 21,702 restricted stock units from a 2023 grant.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing, so the sentiment is neutral.
Industry Context
Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be informative for investors.
Stakeholder Impact
- Shareholders may use this information to understand executive compensation and stock ownership trends.
Key Dates
| Date | Description |
|---|---|
| 03/01/2022 | Reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/03/2023 | Reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/01/2024 | The reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 05/31/2024 | Acquisition of shares through conversion of performance stock units and restricted stock units. |
| 06/03/2024 | Sale of 1,627 shares to cover tax withholding obligations. |
| 06/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.